Harvard Bioscience Inc (HBIO) Stock Price

HBIOStock

$7.93+52.50%52W

Market Cap$36.10M

P/E—

PEG Ratio1.31

Div yield—

Beta1.51

HBIO Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)24.56%

Price vs S&P 500 (4W)24.13%

PEG Ratio1.31

VGM Score60.79

P/CF (Annual)4.33x

Book Value / Share (Quarterly)$2.23

P/TBV (Annual)4.89x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-8.59%

Cash Flow / Share (Quarterly)$0.28

Price vs S&P 500 (YTD)5.71%

Gross Margin (TTM)58.42%

Net Profit Margin (TTM)-11.44%

EPS (TTM)$-2.20

10-Day Avg Trading Volume0.02M

EPS Excl Extra (TTM)$-2.20

Revenue Growth (5Y)-3.25%

EPS (Annual)$-12.77

ROI (Annual)-114.31%

Gross Margin (Annual)57.67%

Net Profit Margin (5Y Avg)-18.07%

Cash / Share (Quarterly)$1.57

Revenue Growth QoQ (YoY)-4.68%

ROA (Last FY)-70.81%

Revenue Growth TTM (YoY)-6.42%

EBITD / Share (TTM)$0.53

ROE (5Y Avg)-90.12%

Operating Margin (TTM)-1.54%

Cash Flow / Share (Annual)$1.09

P/B Ratio2.90x

P/B Ratio (Quarterly)2.17x

Net Income / Employee (Annual)$-179,400

EV / Revenue (TTM)0.68x

Net Interest Coverage (TTM)-10.67x

ROA (TTM)-12.38%

EV / EBITDA (TTM)24.60x

EPS Incl Extra (Annual)$-12.77

Current Ratio (Annual)2.20x

Quick Ratio (Quarterly)1.06x

3-Month Avg Trading Volume0.02M

52-Week Price Return52.50%

EV / Free Cash Flow (Annual)11.97x

Revenue / Employee (TTM)$270,700

Tangible BV / Share (Quarterly)$0.70

P/S Ratio (Annual)0.34x

Asset Turnover (Annual)1.08x

52-Week High$9.40

Operating Margin (5Y Avg)-13.36%

EPS Excl Extra (Annual)$-12.77

CapEx CAGR (5Y)10.13%

Tangible BV CAGR (5Y)-32.50%

26-Week Price Return36.49%

Quick Ratio (Annual)1.25x

13-Week Price Return33.28%

Total Debt / Equity (Annual)2.61x

Current Ratio (Quarterly)1.99x

Enterprise Value$58.25M

Revenue / Share Growth (5Y)49.11%

Asset Turnover (TTM)1.08x

Book Value / Share Growth (5Y)9.55%

Revenue / Employee (Annual)$273,900

Inventory Turnover (Annual)1.66x

Pretax Margin (Annual)-66.30%

Cash / Share (Annual)$1.93

3-Month Return Std Dev49.89%

Gross Margin (5Y Avg)57.39%

Net Income / Employee (TTM)$-31,000

EBITDA Interim CAGR (5Y)-71.12%

ROE (Last FY)-412.84%

Net Interest Coverage (Annual)-0.69x

EPS Basic Excl Extra (Annual)$-12.77

P/FCF (TTM)4.27x

Receivables Turnover (TTM)6.10x

EV / Free Cash Flow (TTM)45.47x

Total Debt / Equity (Quarterly)3.60x

EPS Incl Extra (TTM)$-2.20

Receivables Turnover (Annual)5.60x

ROI (TTM)-20.12%

P/S Ratio (TTM)0.34x

Pretax Margin (5Y Avg)-17.83%

Revenue / Share (Annual)$19.50

Tangible BV / Share (Annual)$1.36

Forward P/E24.70x

Free OCF CAGR (5Y)-9.87%

Price vs S&P 500 (52W)33.94%

Year-to-Date Return18.54%

5-Day Price Return5.03%

EPS Normalized (Annual)$-12.77

ROA (5Y Avg)-17.96%

Net Profit Margin (Annual)-65.51%

Month-to-Date Return30.00%

Cash Flow / Share (TTM)$0.09

EBITD / Share (Annual)$-10.31

Operating Margin (Annual)-57.55%

LT Debt / Equity (Annual)2.61x

P/CF (TTM)9.46x

ROI (5Y Avg)-27.60%

LT Debt / Equity (Quarterly)3.60x

EPS Basic Excl Extra (TTM)$-2.20

P/TBV (Quarterly)6.94x

P/B Ratio (Annual)2.17x

Inventory Turnover (TTM)1.58x

Pretax Margin (TTM)-11.57%

Book Value / Share (Annual)$3.07

Price vs S&P 500 (13W)31.32%

Beta1.51x

P/FCF (Annual)5.99x

Revenue / Share (TTM)$19.12

ROE (TTM)-73.04%

52-Week Low$3.75

vGradeB

gGradeF

mGradeA

vgmGradeB

HBIO Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 11, 2026	-$0.21	-$0.14	+33.33%(+$0.07)
Q4 2025	Mar 12, 2026	$0.35	$0.00	-100.00%(-$0.35)
Q3 2025	Nov 6, 2025	-$0.60	-$0.30	+50.00%(+$0.30)
Q2 2025	Aug 11, 2025	-$0.25	-$0.10	+60.00%(+$0.15)

HBIO Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.00

Industry Peers — Lab Analytical Instruments(26)

Symbol	Value Score	Growth Score	Momentum Score	Price
HBIOHarvard Bioscience Inc	B	F	A	$7.93
AAgilent Technologies Inc.	D	C	B	$153.84
WATWaters Corp	D	C	B	$414.69
ILMNIllumina Inc	D	D	A	$215.59
MTDMettler-Toledo International	D	C	B	$1398.58
RVTYRevvity, Inc.	C	D	A	$128.80
BIOBio-Rad Laboratories, Inc.Class A	C	D	B	$387.70
AVTRAvantor, Inc.	B	F	A	$14.58
BIO.BBio-Rad Laboratories, Inc. Class B	C	D	B	$365.08
BRKRBruker Corporation	D	D	B	$57.08
TXG10x Genomics, Inc. Class A Common Stock	F	D	A	$61.54
ALMRAlamar Biosciences, Inc. Common Stock	—	—	B	$30.71
CTKBCytek Biosciences, Inc. Common Stock	C	C	B	$4.68
MASS908 Devices Inc. Common Stock	C	C	B	$10.73
PACBPacific Biosciences of California, Inc.	D	C	C	$1.40
PREPrenetics Global Limited Class A Ordinary Share	C	D	A	$25.76
EYPTEyePoint, Inc. Common Stock	D	F	F	$4.48
LABStandard BioTools Inc. Common Stock	A	F	D	$0.64
QTRXQuanterix Corporation Common Stock	A	C	D	$2.64
NAUTNautilus Biotechnolgy, Inc. Common Stock	—	—	C	$0.89
SEERSeer, Inc. Class A Common Stock	C	D	C	$1.98
RPIDRapid Micro Biosystems, Inc. Class A Common Stock	C	B	D	$1.57
PRPOPrecipio, Inc. Common Stock	C	A	B	$28.85
ASTCAstrotech Corporation (DE) Common Stock	C	C	C	$7.15
BNGOBionano Genomics, Inc. Common Stock	A	C	D	$1.17
HLTHTema Healthcare AI ETF	—	F	F	$28.54
PRENWPrenetics Global Limited Warrant	—	—	F	$0.01

About Harvard Bioscience Inc

Harvard Bioscience designs and manufactures specialized instruments and products for life sciences research, pharmaceutical discovery, and drug development. The company serves customers globally through direct and distribution channels, with brands including Harvard Apparatus, DSI, Buxco, Biochrom, and others. Most revenue is generated in the United States, though the company maintains operations across North America, Europe, and China.